Serine protease PKF of Acinetobacter baumannii results in serum resistance and suppression of biofilm formation

Journal of Infectious Diseases

Volumn 207, Issue 7, 2013, Pages 1128-1134

  King, Lauren B ^a   Pangburn, Michael K ^b   McDaniel, Larry S ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT TYLER   (United States)

Author keywords

Acinetobacter baumannii; biofilm; complement; innate immunity; serum resistance

Indexed keywords

PROTEINASE INHIBITOR; SERINE PROTEINASE; SERINE PROTEINASE PKF; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL VIRULENCE; BIOFILM; COMPLEMENT ACTIVATION; CONTROLLED STUDY; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEINASE INHIBITION; SERUM; SERUM RESISTANCE; SURVIVAL; WILD TYPE;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; BACTERIAL ADHESION; BACTERIAL PROTEINS; BIOFILMS; BLOOD BACTERICIDAL ACTIVITY; CLONING, MOLECULAR; COMPLEMENT PATHWAY, ALTERNATIVE; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; RECOMBINANT PROTEINS; SERINE PROTEASES; SULFONES;

EID: 84874734831     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis939     Document Type: Article

References (29)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21:538-82.
2. Doi Y, Kandiah S, Hariri RS, Harrison LH. Natural history of multidrug-resistant Acinetobacter baumannii carriage in intensive care units. Infect Control Hosp Epidemiol 2012; 33:642-3.
3. Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2009; 35:219-26.
4. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010; 5: e10034.
5. Roca I, Espinal P, Vila-Farres X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 2012; 3:148.
6. Fournier PE, Vallenet D, Barbe V, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006; 2: e7.
7. Seputiene V, Povilonis J, Suziedeliene E. Novel variants of AbaR resistance islands with a common backbone in Acinetobacter baumannii isolates of European clone II. Antimicrob Agents Chemother 2012; 56:1969-73.
8. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51:3471-84. (Pubitemid 47519332)
9. King LB, Swiatlo E, Swiatlo A, McDaniel LS. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol Med Microbiol 2009; 55:414-21.
10. Garcia A, Solar H, Gonzalez C, Zemelman R. Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum. J Med Microbiol 2000; 49: 1047-50.
11. Gening ML, Maira-Litran T, Kropec A, et al. Synthetic {beta}-(1->6)- linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010; 78:764-72.
12. Russo TA, Luke NR, Beanan JM, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 2010; 78:3993-4000.
13. Blom AM, Hallstrom T, Riesbeck K. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol 2009; 46:2808-17.
14. Lee VT, Schneewind O. Protein secretion and the pathogenesis of bacterial infections. Genes Dev 2001; 15:1725-52. (Pubitemid 32905631)
15. Sandkvist M. Type II secretion and pathogenesis. Infect Immun 2001; 69:3523-35. (Pubitemid 32493264)
16. Djeribi R, Bouchloukh W, Jouenne T, Menaa B. Characterization of bacterial biofilms formed on urinary catheters. Am J Infect Control 2012; 40:845-9.
17. Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol 2011; 62:328-38.
18. Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litran T. The pgaABCD locus of Acinetobacter baumannii encodes the production of polybeta- 1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 2009; 191:5953-63.
19. Samuelsen O, Haukland HH, Ulvatne H, Vorland LH. Anti-complement effects of lactoferrin-derived peptides. FEMS Immunol Med Microbiol 2004; 41:141-8. (Pubitemid 38625716)
20. Servais G, Walmagh J, Duchateau J. Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50). J Immunol Methods 1991; 140:93-100.
21. Dallo SF, Weitao T. Insights into acinetobacter war-wound infections, biofilms, and control. Adv Skin Wound Care 2010; 23:169-74.
22. Carniol K, Gilmore MS. Signal transduction, quorum-sensing, and extracellular protease activity in Enterococcus faecalis biofilm formation. J Bacteriol 2004; 186:8161-3. (Pubitemid 39603204)
23. Iwase T, Uehara Y, Shinji H, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 2010; 465:346-9.
24. Rohde H, Burdelski C, Bartscht K, et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol 2005; 55:1883-95. (Pubitemid 40445220)
25. Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev 2009; 73:310-47.
26. Fluhrer R, Fukumori A, Martin L, et al. Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation. J Biol Chem 2008; 283:30121-8.
27. Mascher T, Helmann JD, Unden G. Stimulus perception in bacterial signal-transducing histidine kinases. Microbiol Mol Biol Rev 2006; 70:910-38. (Pubitemid 44958261)
28. Mitrophanov AY, Groisman EA. Signal integration in bacterial twocomponent regulatory systems. Genes Dev 2008; 22:2601-11.
29. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84: 579-621. (Pubitemid 38365493)